| Regenerative Medical Technology Group Inc. (RMTG) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Jun-30 | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | ||||||||||||||||||||||||||||
| Fiscal Period | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | ||||||||||||||||||||||||||||
| Operating Cash Flow | 331,974$ | 102,124$ | 38,196$ | (203,731$) | (598,093$) | 57,109$ | 379,393$ | 272,942$ | 90,398$ | 107,966$ | (29,399$) | 10,138$ | (406,713$) | 6,775$ | (154,860$) | (96,939$) | (92,096$) | (69,028$) | (64,682$) | (48,450$) | (134,679$) | (86,570$) | (92,626$) | (73,869$) | (68,209$) | (67,625$) | (34,937$) | ||||||||||||||||||||||
| Investing Cash Flow | (43,499$) | (315,394$) | (267,172$) | (224,829$) | (50,000$) | (53,608$) | (52,657$) | (59,154$) | (284,002$) | (91,387$) | (4,721$) | (5,486$) | 0$ | (125,000$) | 0$ | ||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 43,499$ | 315,394$ | 267,172$ | 224,829$ | 50,000$ | 53,608$ | 52,657$ | 59,154$ | 284,002$ | 91,387$ | 4,721$ | 5,486$ | 0$ | ||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | (26,619$) | 318,000$ | 0$ | 0$ | (300,000$) | 0$ | 0$ | (9,850$) | 900,000$ | 80,000$ | 265,000$ | 119,300$ | 52,600$ | 71,801$ | 94,559$ | 126,140$ | 62,370$ | 74,392$ | 76,750$ | 91,914$ | 28,668$ | ||||||||||||||||||||||||||||
| End Cash Position | 1,323,304$ | 1,061,448$ | 956,718$ | 1,185,695$ | 1,614,254$ | 1,222,929$ | 1,165,820$ | 836,427$ | 617,093$ | 579,352$ | 530,540$ | 1,143,941$ | 1,225,190$ | 1,636,624$ | 1,645,185$ | 2,978,525$ | 787,674$ | 42,534$ | 59,473$ | 11,569$ | 11,379$ | 23,379$ | 28$ | 40,148$ | 578$ | 30,834$ | 30,311$ | 25,770$ | 7,750$ | ||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | 288,475$ | (213,270$) | (228,976$) | (428,560$) | (598,093$) | 57,109$ | 329,393$ | 219,334$ | 37,741$ | 48,812$ | (313,401$) | (81,249$) | (411,434$) | 1,289$ | (154,860$) | (96,939$) | (92,096$) | (69,028$) | (64,682$) | (48,450$) | (134,679$) | (86,570$) | (92,626$) | (73,869$) | (68,209$) | (67,625$) | (34,937$) | ||||||||||||||||||||||